acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70518-1363 -
Package NDC
70518-1363-0 -
Package NDC
70518-1363-1 -
Package NDC
70518-1363-2 -
Application number
ANDA204314 -
SPL ID
4bd3791a-9cbb-3c48-e063-6394a90a6d7a -
SPL set ID
8fdabab2-bc93-48ab-9c13-d22ec90fdcfc -
UNII
X4HES1O11F -
RxCUI
197311
What the source publishes
- Labeler
- REMEDYREPACK INC.
- Active ingredients
- acyclovir
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "acyclovir",
"splId": "4bd3791a-9cbb-3c48-e063-6394a90a6d7a",
"labels": [
{
"setId": "8fdabab2-bc93-48ab-9c13-d22ec90fdcfc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8fdabab2-bc93-48ab-9c13-d22ec90fdcfc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8fdabab2-bc93-48ab-9c13-d22ec90fdcfc"
}
],
"routes": [
"ORAL"
],
"labeler": "REMEDYREPACK INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "15 TABLET in 1 BOTTLE, PLASTIC (70518-1363-0)",
"package_ndc": "70518-1363-0",
"identifierStatus": "well-formed",
"marketing_start_date": "20180809"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-1363-1)",
"package_ndc": "70518-1363-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20181227"
},
{
"sample": false,
"description": "30 TABLET in 1 BLISTER PACK (70518-1363-2)",
"package_ndc": "70518-1363-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20260217"
}
],
"productId": "70518-1363_4bd3791a-9cbb-3c48-e063-6394a90a6d7a",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "70518-1363",
"deaSchedule": null,
"genericName": "acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "400 mg/1"
}
],
"applicationNumber": "ANDA204314",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180809",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"197311"
],
"spl_set_id": [
"8fdabab2-bc93-48ab-9c13-d22ec90fdcfc"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"REMEDYREPACK INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70518-1363_4bd3791a-9cbb-3c48-e063-6394a90a6d7a"